Clinical characteristics and genetic analysis of childhood acute lymphoblastic leukemia with hemophagocytic lymphohistiocytosis: A Japanese retrospective study by the Kyushu-Yamaguchi Children's Cancer Study Group

International Journal of Hematology

Volumn 100, Issue 1, 2014, Pages 70-78

  Moritake, Hiroshi ^a,b   Kamimura, Sachiyo ^a,b   Nunoi, Hiroyuki ^a,b   Nakayama, Hideki ^a,c   Suminoe, Aiko ^a,d   Inada, Hiroko ^a,e   Inagaki, Jiro ^a,f   Yanai, Fumio ^a,g   Okamoto, Yasuhiro ^a,h   Shinkoda, Yuichi ^a,i   Shimomura, Maiko ^a,j   Itonaga, Nobuyoshi ^a,k   Hotta, Noriko ^a,l   Hidaka, Yasufumi ^a,m   Ohara, Osamu ⁿ   Yanagimachi, Masakatsu ^o   Nakajima, Noriko ^p   Okamura, Jun ^a,f   Kawano, Yoshifumi ^a,h  

^a Kyushu Yamaguchi Children's Cancer Study Group (KYCCSG)   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c FUKUOKA HIGASHI MEDICAL CENTER   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NATIONAL KYUSHU CANCER CENTER   (Japan)

^g FUKUOKA UNIVERSITY   (Japan)

^h KAGOSHIMA UNIVERSITY   (Japan)

ⁱ Kagoshima City Hospital   (Japan)

^j YAMAGUCHI UNIVERSITY   (Japan)

^k OITA PREFECTURAL HOSPITAL   (Japan)

^l Tokuyama Central Hospital   (Japan)

^m KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

ⁿ KAZUSA DNA RESEARCH INSTITUTE   (Japan)

^o YOKOHAMA CITY UNIVERSITY   (Japan)

^p NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

more..

Author keywords

Acute lymphoblastic leukemia; Cytomegalovirus reactivation; Hemophagocytic lymphohistiocytosis; Intravenous immunoglobulin; Single nucleotide polymorphisms

Indexed keywords

CYCLOSPORIN A; DOXORUBICIN; ETOPOSIDE; GANCICLOVIR; IMMUNOGLOBULIN G; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CASE REPORT; CHILD; CHILDHOOD CANCER; CHROMOSOME 6; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ERYTHEMA INFECTIOSUM; FEMALE; GENETIC ANALYSIS; HEMOPHAGOCYTIC SYNDROME; HUMAN; LEUKEMIA CELL; MAINTENANCE THERAPY; MALE; RETROSPECTIVE STUDY; VIRUS REACTIVATION; BONE MARROW; COMPLICATION; GENETICS; HUMAN PARVOVIRUS B19; ISOLATION AND PURIFICATION; JAPAN; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MAINTENANCE CHEMOTHERAPY; PARVOVIRIDAE INFECTIONS; PATHOLOGY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SINGLE NUCLEOTIDE POLYMORPHISM; VIROLOGY;

ADOLESCENT; BONE MARROW; CHILD; FEMALE; HUMANS; JAPAN; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MAINTENANCE CHEMOTHERAPY; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES;

EID: 84904364746     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-014-1591-1     Document Type: Article

References (30)

1. Janka G, zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program. 2005;82-88.
2. Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86:58-65. (Pubitemid 47204491)
3. Lackner H, Urban C, Sovinz P, Benesch M, Moser A, Schwinger W. Hemophagocytic lymphohistiocytosis as severe adverse event of antineoplastic treatment in children. Haematologica. 2008;93:291-4. (Pubitemid 351397720)
4. Trebo MM, Attarbaschi A, Mann G, Minkov M, Kornmüller R, Gadner H. Histiocytosis following T-acute lymphoblastic leukemia: a BFM study. Leuk Lymphoma. 2005;46:1735-41. (Pubitemid 43203107)
5. Nagatoshi Y, Matsuzaki A, Suminoe A, Inada H, Ueda K, Kawakami K, et al. Randomized trial to compare LSA2L2 type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2010;55:239-47.
6. Henter JI, Horne A, Aricò M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124-31.
7. Katano H, Kano M, Nakamura T, Kanno T, Asanuma H, Sata T. A novel real-time PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnoses. J Med Virol. 2011;83:322-30.
8. Yanagimachi M, Goto H, Miyamae T, Kadota K, Imagawa T, Mori M, et al. Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children. J Clin Immunol. 2011;31:946-51.
9. Bader P, Kreyenberg H, Henze GH, Eckert C, Reising M, Willasch A, et al. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM study group. J Clin Oncol. 2009;27:377-84.
10. zur Stadt U, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet. 2005;14:827-834. (Pubitemid 40403278)
11. Berthou C, Marolleau JP, Lafaurie C, Soulié A, Dal Cortivo L, Bourge JF, et al. Granzyme B and perforin lytic proteins are expressed in CD34 + peripheral blood progenitor cells mobilized by chemotherapy and granulocyte colony-stimulating factor. Blood. 1995;86:3500-3506.
12. Hagn M, Schwesinger E, Ebel V, Sontheimer K, Maier J, Beyer T, et al. Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J Immunol. 2009;183:1838-45.
13. Bruno AP, Lautier D, d'Orgeix AT, Laurent G, Quillet-Mary A. Acute myeloblastic leukemic cells acquire cellular cytotoxicity under genotoxic stress: implication of granzyme B and perforin. Blood. 2000;96:1914-20. (Pubitemid 30661077)
14. Jahrsdörfer B, Blackwell SE, Wooldridge JE, Huang J, Andreski MW, Jacobus LS, et al. B-chronic lymphocytic leukemia cells and other B cell can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation. Blood. 2006;108:2712-9.
15. Rouphael NG, Talati NJ, Vaughan C, Conningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lancet Infect Dis. 2007;7:814-22. (Pubitemid 350152044)
16. Imashuku S, Hibi S, Sako M, Ishida Y, Mugishima H, Chen J, et al. Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood. 1995;86:4706-7.
17. Amenomori M, Migita K, Miyashita T, Yoshida S, Ito M, Eguchi K, et al. Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Stills disease. Clin Exp Rheumatol. 2005;23:100-2. (Pubitemid 40424767)
18. Oloomi Z, Moayeri H. Cytomegalovirus infection-associated hemophagocytic syndrome. Arch Iran Med. 2006;9:284-7. (Pubitemid 44122246)
19. Hardikar W, Pang K, Al-Hebbi H, Curtis N, Couper R. Successful treatment of cytomegalovirus-associated haemophagocytic syndrome following paediatric orthotopic liver transplantation. J Pediatr Child Health. 2006;42:389-91. (Pubitemid 43823345)
20. Knorr B, Kessler U, Pöschl J, Fickenscher H, Linderkamp O. A haemophagocytic lymphohistiocytosis (HLH)-like picture following breastmilk transmitted cytomegalovirus infection in apreterm infant. Scand J Infect Dis. 2007;39:173-6. (Pubitemid 46277321)
21. Te Poele EM, de Bont ES, Marike Boezen H, Revesz T, Bökkerink JP, Beishuizen A, et al. Dexamethasone in the maintenance phase of acute lymphoblastic leukemia treatment: Is the risk of lethal infections too high? Eur J Cancer. 2007;43:2532-2536. (Pubitemid 350103545)
22. Moritake H, Kamimura S, Kojima H, Shimonodan H, Harada M, Sugimoto T, et al. Cytomegalovirus retinitis as an adverse immunological effect of pulses of vincristine and dexamethasone in maintenance therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60:329-31.
23. Pagel J, Beutel K, Lehmberg K, Koch F, Maul-Pavicic A, Rohlfs AK, et al. Distinct mutations in STXBP2 are associated with variable clinical presentation in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood. 2012;119:6016-24.
24. Yanagimachi M, Naruto T, Miyamae T, Hara T, Kikuchi M, Hara R, et al. Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis. J Rheumatol. 2011;38:769-74.
25. Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461-73. (Pubitemid 37456808)
26. Zhang K, Biroschak J, Glass DN, Thompson SD, Finkel T, Passo MH, et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis Rhuem. 2008;58:2892-6.
27. Yamamoto K, Ishii E, Horiuchi H, Ueda I, Ohga S, Nishi M, et al. Mutations of syntaxin 11 and SNAP23 genes as causes of familial hemophagocytic lymphohistiocytosis were not found in Japanese people. J Hum Genet. 2005;50:600-3. (Pubitemid 41666980)
28. zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009;85:482-492.
29. Côte M, Ménager MM, Burgess A, Mahlaoui N, Picard C, Schaffner C, et al. Munc-18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest. 2009;119:3765-73.
30. Libby E, Movva S, Quintana D, Abdul-Jaleel M, Das A. Cytomegalovirus retinitis during chemotherapy with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone. J Clin Oncol. 2010;28:e661-2.